$0.677500
0.00250.37%
At Close: -
$0.641300
-0.04-5.34%
After Hours: 7:35 AM EDT
15 minutes delayed
Comments
Loading...
Hepion Pharmaceuticals (NASDAQ:HEPA) Stock, Earnings Estimates, EPS, And Revenue
Hepion Pharmaceuticals reports earnings on a quarterly basis. These quarterly earnings reports give investors a glimpse into financial results from a company for a 3 month period. Earnings reports almost always include EPS and Revenue results.
Earnings Date
Aug 13
EPS
$-0.680
Quarterly Revenue
$0K
Annual Revenue
(as of Jun 30)
(as of Jun 30)
–
Analyze the earnings history of Hepion Pharmaceuticals using advanced sorting and filters.
Data brought to you by Benzinga APIs
Hepion Pharmaceuticals (HEPA) Earnings Per Share
Quarterly Earnings Surprise Amount
| Fiscal Quarter End | Date Reported | Actual EPS | Estimated EPS | Surprise % |
|---|---|---|---|---|
| Mar 2024 | 2024-04-16 | $-2.42 | $-2.63 | 7.98 % |
| Sep 2023 | 2023-11-20 | $-2.74 | $-2.16 | -26.9 % |
| Mar 2023 | 2023-04-10 | $-2.60 | $-2.80 | 7.14 % |
| Dec 2020 | 2021-03-31 | $0.20 | $-4.00 | 105.0 % |
Hepion Pharmaceuticals (HEPA) Revenue
Quarterly Revenue Surprise Amount
| Fiscal Quarter End | Date Reported | Actual Revenue | Estimated Revenue | Surprise % |
|---|---|---|---|---|
FAQ
When is Hepion Pharmaceuticals (NASDAQ:HEPA) reporting earnings?
Hepion Pharmaceuticals (HEPA) is scheduled to report earnings on November 18, 2024. The last reported earnings were for reported on August 13, 2024 for Q2.
What were the latest earnings per share (EPS) for Hepion Pharmaceuticals (NASDAQ:HEPA)?
The Actual EPS was $-0.68, which missed the estimate of $0.00.
What were Hepion Pharmaceuticals’s (NASDAQ:HEPA) revenues?
The Actual Revenue was $0K, which hit the estimate of $0K.
Browse earnings estimates, EPS, and revenue on all stocks.